Key Coverage Facts Coverage varies significantly by plan even within the same insurer, different employer plans have different formularies Coverage varies by employer size: 16% of mid-size employers (200-999 workers), 30% of large employers (1,000-4,999), and 43% of very large employers (5,000+) cover GLP-1 medications for weight loss [1] More than 88% of patients with coverage face prior authorization or other restrictionsyour doctor must get approval before you can fill it Medicare Part D excludes weight loss drugs by federal statute (may cover for CV risk reduction indication) About a dozen state Medicaid programs cover GLP-1s for obesity, though policies are evolving [2] Coverage by Plan Type Already denied
DOI.org (Crossref) , Nudy, Matthew, et al
Legal status (US): MK-677 is not FDA-approved for any human indication
The fact is that GP audits (and no clinical evidence or patient involvement of any kind) eventually made three monthly injections the optimal maintenance dose of B12
A press release of the phase 2 obesity trial (MOMENTUM-1) reports a mean WL up to 15.6% (placebo-adjusted 13.4%) at 48 weeks with the 2.4 mg dose
A note for frequent travelers : If youre often on the go, consider investing in a small insulated travel case for your weight loss medication
